ผลิตภัณฑ์นิวตราซูติคอลในการลดน้ำหนัก
บทคัดย่อ
No available
References
Disease Control Priorities Project (DCPP), Risk factors: Millions of deaths could be prevented by reducing risk factor exposure. 2006, World Bank: Washington.
วิชัย เอกพลากร และคณะ. รายงานการสำรวจสุขภาพประชาชนไทยโดยการตรวจร่างกาย ครั้งที่ 4 พ.ศ. 2551-2, วิชัย เอกพลากร, บรรณาธิการ. ไม่ปรากฏปี, สำนักงานสำรวจสุขภาพประชาชน
Celleno L, Tolaini MV, DûAmore A, Perricone NV, Preuss HG. A dietary supplement containing standardized
Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci 2007;4:45-52.
Grube B, Chong WF, Chong PW, Riede L. Weight reduction and maintenance with IQP-PV-101: a 12-week randomized controlled study with a 24-week open label period. Obesity 2014;22:645-51
Udani J, Singh BB. Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary
fractionated white bean extract. Altern Ther Health Med. 2007;13:32-37.
Onakpoya I, Aldaas S, Terry R, Ernst E. The efficacy of Phaseolus vulgaris as a weight-loss supplement:
a systematic review and meta-analysis of randomised clinical trials. Br J Nutr 2011;106:196-202.
Gallaher CM, Munion J, Hesslink R Jr, Wise J, Gallaher DD. Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J Nutr. 2000;130:2753-2759.
Gades, M.D., & Stern, J.S.. Chitosan supplementation and fat absorption in men and women. Journal of the American Dietetic Association.2005; 105(1),72-77.
Jull AB, Ni Mhurchu C, Bennett DA, Dunshea-Mooij CA, Rodgers A. Chitosan for overweight or obesity. Cochrane Database Syst Rev 2008:CD003892.
Haaz S, Fontaine KR, Cutter G, Limdi N, Perumean-Chaney S, Allison DB. Citrus aurantium and synephrine
alkaloids in the treatment of overweight and obesity: an update. Obes Rev 2006;7:79-88.
Stohs SJ, Preuss HG, Shara M. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid psynephrine. Int J Med Sci 2012;9:527-38.
Haaz S, Fontaine KR, Cutter G, Limdi N, Perumean-Chaney S, Allison DB. Citrus aurantium and synephrine
alkaloids in the treatment of overweight and obesity: an update. Obes Rev. 2006;7:79-88.
Colker CM, Kaiman DS, Torina GC, Perlis T, Street C. Effects of Citrus aurantium extract, caffeine, and
St. Johnûs Wort on body fat loss, lipid levels, and mood states in overweight healthy adults. Current Therapeutic Research 1999;60:145-53.
Stohs SJ, Preuss HG, Shara M. A review of the human clinical studies involving Citrus aurantium (bitter
orange) extract and its primary protoalkaloid psynephrine. Int J Med Sci 2012;9:527-38.
Dangerous supplements: what you donût know about these 12 ingredients could hurt you. Consum Rep.
;75:16-20.
Bui, L.T., Nguyen, D.T., & Ambrose, P.J.. Blood pressure and heart rate effects following a single dose of
bitter orange. The Annals of Pharmacotherapy. 2006;40(1), 53-57.
Nykamp, D.L., Fackih, M.N., & Compton, A.L.. Possible association of acute lateral-wall myocardial infarction
and bitter orange supplement. The Annals of Pharmacotherapy. 2004;38(5):812-816.
Gange, C.A., Madias, C., Felix-Getzik, E.M., Weintraub, A.R., & Estes, N.A., 3rd. Variant angina associated with bitter orange in a dietary supplement. Mayo Clinic Proceedings. 2006;81(4), 545-548.
Dulloo A, Geissler C, Horton T, Miller D. Normal caffeine consumption: influence on thermogenesis and
daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr. 1989;49:44-50.
Manore MM. Dietary supplements for improving body composition and reducing body weight: where is
the evidence? Int J Sport Nutr Exerc Metab 2012; 22:139-54.
Astrup A, Toubro S, Cannon S, Hein P, Breum L, Madsen J. Caffeine: a double-blind, placebo-controlled
study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr 1990;51:759-67.
Acheson KJ, Zahorska-Markiewicz B, Anantharaman K, Jequier E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr.1980;33:989-997.
Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, et al. Herbal ephedra/caffeine for weight
loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord 2002;26:593-604.
Andersen T, Fogh J. Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients. J Hum Nutr Diet 2001;14:243-50.
Lopez-Garcia E, van Dam RM, Rajpathak S, Willett WC, Manson JE, Hu FB. Changes in caffeine intake
and long-term weight change in men and women. Am J Clin Nutr 2006;83:674-80.
Phung OJ, Baker WL, Matthews LJ, Lanosa M, Thorne A, Coleman CI. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr. 2010;91:73-81.
U.S. Food and Drug Administration. FDA to Investigate Added Caffeine.2013.
Yen M, Ewald MB. Toxicity of weight loss agents. J Med Toxicol 2012;8:145-52.
Wang H, Wen Y, Du Y, et al. Effects of catechin enriched green tea on body composition. Obesity. 2010;18:773-779.
Jurgens TM, Whelan AM, Killian L, Doucette S, Kirk S, Foy E. Green tea for weight loss and weight maintenance
in overweight or obese adults. Cochrane Database Syst Rev 2012;12:CD008650.
Phung OJ, Baker WL, Matthews LJ, Lanosa M, Thorne A, Coleman CI. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr 2010;91:73-81.
Hursel R, Viechtbauer W, Westerterp-Plantenga MS. The effects of green tea on weight loss and weight
maintenance: a meta-analysis. Int J Obes. 2009;33: 956-961.
Jurgens TM, Whelan AM, Killian L, Doucette S, Kirk S, Foy E. Green tea for weight loss and weight maintenance
in overweight or obese adults. Cochrane Database Syst Rev 2012;12:CD008650.
Frank J, George TW, Lodge JK, Rodriguez-Mateos AM, Spencer JP, Minihane AM, et al. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr 2009;139:58-62.
Abourashed EA, El-Alfy AT, Khan IA, Walker L. Ephedra in perspective: a current review. Phytother Res. 2003;17:703-712.
Chen WL, Tsai TH, Yang CC, Kuo TB. Effects of ephedra on autonomic nervous modulation in healthy young adults. J Ethnopharmacol. 2010;130:563-568.
Andraws R, Chawla P, Brown DL. Cardiovascular effects of ephedra alkaloids: a comprehensive review.
Prog Cardiovasc Dis.2005;47:217-225.
Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003;289:1537-45.
U.S. Food and Drug Administration. FDA Issues Regulation Prohibiting Sale of Dietary Supplements Containing Ephedrine Alkaloids and Reiterates its Advice that Consumers Stop Using these Products. 2004.
Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary
supplements containing ephedra alkaloids. N Engl J Med 2000;343:1833-8.
Davies KM, Heaney RP, Recker RR, Lappe JM, Barger-Lux MJ, Rafferty K, et al. Calcium intake and body weight. J Clin Endocrinol Metab 2000;85:4635-8.
Heaney RP. Normalizing calcium intake: projected population effects for body weight. J Nutr 2003; 133:268S-70S.
Parikh SJ, Yanovski JA. Calcium intake and adiposity. Am J Clin Nutr 2003;77:281-7.
Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J
;14:1132-8.
Zemel, M.B. Role of calcium and dairy products in energy partitioning and weight management. The
American Journal of Clinical Nutrition. 2004; 79(5), 907S-912S.
Zemel, M.B. The role of dairy foods in weight management. Journal of the American College of Nutrition.
; 24(6,Suppl.) 537S-546S.
Jacobsen R, Lorenzen JK, Toubro S, Krog-Mikkelsen I, Astrup A. Effect of short-term high dietary calcium
intake on 24-h energy expenditure, fat oxidation, and fecal fat excretion. Int J Obes (Lond) 2005;29:292-301.
Christensen R, Lorenzen JK, Svith CR, Bartels EM, Melanson EL, Saris WH, et al. Effect of calcium from dairy and dietary supplements on faecal fat excretion excretion: a meta-analysis of randomized controlled trials.
Obes Rev 2009;10:475-86.
Bendsen, N.T., Hother, A.L., Jensen, S.K., Lorenzen, J.K., & Astrup, A. Effect of dairy calcium on fecal fat
excretion: A randomized crossover trial. International Journal of Obesity. 2008; 32(12), 1816-1824.
Astrup, A., Chaput, J.P., Gilbert, J.A., & Lorenzen, J.K. Dairy beverages and energy balance. Physiology & Behavior. 2010; 100(1), 67-75.
Yanovski JA, Parikh SJ, Yanoff LB, Denkinger BI, Calis KA, Reynolds JC, et al. Effects of calcium supplementation
on body weight and adiposity in overweight and obese adults: a randomized trial. Ann Intern Med 2009;150:821-9, W145-6.
Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, et al. Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep) 2009:1-420.
Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients
and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-8.
Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann
Intern Med 1997;126:497-504.
Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-83.
Kraemer WJ, Volek JS, Dunn-Lewis C. L-carnitine supplementation: influence upon physiological function.
Curr Sports Med Rep. 2008;7:218-223.
Hathcock JN, Shao A. Risk assessment for carnitine. Regul Toxicol Pharmacol. 2006;46:23-28.
Karlic H, Lohninger A. Supplementation of L-carnitine in athletes: does it make sense? Nutrition.
;20:709-715.
Müller DM, Seim H, Kiess W, Löster H, Richter T. Effects of oral L-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults. Metabolism. 2002;51:1389-1391.
Wutzke KD, Lorenz H. The effect of L-carnitine on fat oxidation, protein turnover, and body composi
tion in slightly overweight subjects. Metabolism. 2004;53:1002-1006.
Villani RG, Gannon J, Self M, Rich PA. L-carnitine supplementation combined with aerobic training
does not promote weight loss in moderately obese women. Int J Sport Nutr Exerc Metab. 2000;10:199-207.
Manore MM. Dietary supplements for improving body composition and reducing body weight: where is
the evidence? Int J Sport Nutr Exerc Metab 2012; 22:139-54.
Tian H, Guo X, Wang X, He Z, Sun R, Ge S, et al. Chromium picolinate supplementation for overweight
or obese adults. Cochrane Database Syst Rev 2013; 11:CD010063.
Onakpoya I, Posadzki P, Ernst E. Chromium supplementation in overweight and obesity: a systematic
review and meta-analysis of randomized clinical trials. Obes Rev 2013;14:496-507.
Egras AM, Hamilton WR, Lenz TL, Monaghan MS. An evidence-based review of fat modifying supplemental
weight loss products. J Obes 2011;2011.
Churruca I, Fernández-Quintela A, Portillo M.P. Conjugated linoleic acid isomers: Differences in metabolism
and biological effects. BioFactors. 2009;35(1):105-111.
Li JJ, Huang CJ, Xie D. Anti-obesity effects of conjugated linoleic acid, docosahexaenoic acid, and
eicosapentaenoic acid. Molecular Nutrition & Food Research. 2008;52(6):631-45.
Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, et al. Conjugated linoleic acid supplementation
for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr. 2004;79:1118-25.
Onakpoya IJ, Posadzki PP, Watson LK, Davies LA, Ernst E. The efficacy of long-term conjugated linoleic
acid (CLA) supplementation on body composition in overweight and obese individuals: a systematic review
and meta-analysis of randomized clinical trials. Eur J Nutr 2012;51:127-34.
Whigham LD, Watras AC, Schoeller DA. Efficacy of conjugated linoleic acid for reducing fat mass: a metaanalysis in humans. Am J Clin Nutr. 2007;85:1203-1211.
Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, et al. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. J Nutr 2007;137:1188-93.
Salas-Salvado J, Marquez-Sandoval F, Bullo M. Conjugated linoleic acid intake in humans: a systematic
review focusing on its effect on body composition, glucose, and lipid metabolism. Crit Rev Food Sci Nutr 2006;46:479-88.
Terpstra AH. Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an
overview of the literature. Am J Clin Nutr 2004;79:352-61.
Silveira MB, Carraro R, Monereo S, Tebar J. Conjugated linoleic acid (CLA) and obesity. Public Health
Nutr 2007;10:1181-6.
Riserus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002;25:1516-21.
Pittler MH, Ernst E. Dietary supplements for bodyweight reduction: a systematic review. Am J Clin Nutr 2004;79:529-36.
Allison DB, Fontaine KR, Heshka S, Mentore JL, Heymsfield SB. Alternative treatments for weight loss:
a critical review. Crit Rev Food Sci Nutr 2001;41:1-28; discussion 39-40.
Egras AM, Hamilton WR, Lenz TL, Monaghan MS. An evidence-based review of fat modifying supplemental
weight loss products. J Obes 2011;2011.
McCarty MF. Promotion of hepatic lipid oxidation and gluconeogenesis as a strategy for appetite control.
Med Hypotheses.1994;42:215-225.
Mattes RD, Bormann L. Effects of (-)-hydroxycitric acid on appetitive variables. Physiol Behav 2000;71:87-94.
Onakpoya I, Hung SK, Perry R, Wider B, Ernst E. The use of garcinia extract (hydroxycitric acid) as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. J Obes 2011;2011:509038.
Chuah LO, Ho WY, Beh BK, Yeap SK. Updates on antiobesity effect of Garcinia Origin (-)-HCA. Evid
Based Complement Alternat Med 2013;2013:751658.
Marquez F, Babio N, Bullo M, Salas-Salvado J. Evalu ation of the safety and efficacy of hydroxycitric acid
or Garcinia cambogia extracts in humans. Crit Rev Food Sci Nutr 2012;52:585-94.
Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia (hydroxycitric
acid) as a potential antiobesity agent: a randomized controlled trial. JAMA 1998;280:1596-600.
American Herbal Products Association. Botanical Safety Handbook. 2nd ed. Boca Raton, Florida: CRC
Press; 2013.
Farah A, Monteiro M, Donangelo CM, Lafay S. Chlorogenic acids from green coffee extract are highly
bioavailable in humans. J Nutr 2008;138:2309-15.
Onakpoya I, Terry R, Ernst E. The use of green coffee extract as a weight loss supplement: a systematic
review and meta-analysis of randomised clinical trials. Gastroenterol Res Pract 2011;2011.
Onakpoya I, Hunt K, Wider B, Ernst E. Pyruvate supplementation for weight loss: a systematic review and meta-analysis of randomized clinical trials. Crit Rev Food Sci Nutr 2014;54:17-23.
Koh-Banerjee PK, Ferreira MP, Greenwood M, Bowden RG, Cowan PN, Almada AL, et al. Effects of
calcium pyruvate supplementation during training on body composition, exercise capacity, and metabolic
responses to exercise. Nutrition 2005;21:312-9.
Kalman D, Colker CM, Wilets I, Roufs JB, Antonio J. The effects of pyruvate supplementation on body
composition in overweight individuals. Nutrition 1999;15:337-40.
Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization, and nitrogen metabolism with a
25-MJ/d low-energy diet supplemented with pyruvate. Am J Clin Nutr 1992;56:630-5.
Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am
Diet Assoc. 2008;108(10):1716-1731.
Jones JR, Lineback DM, Levine MJ. Dietary reference intakes: implications for fiber labeling and consumption:
a summary of the International Life Sciences Institute North America Fiber Workshop, June 1-2, 2004, Washington, DC. Nutr Rev. 2006;64:31-38.
Henry DA, Mitchell AS, Aylward J, Fung MT, McEwen J, Rohan A. Glucomannan and risk of oesophageal
obstruction. Br Med J (Clin Res Ed) 1986;292:591-2.
Sood N, Baker WL, Coleman CI. Effect of glucomannan on plasma lipid and glucose concentrations,
body weight, and blood pressure: systematic review and meta-analysis. Am J Clin Nutr 2008;88:1167-75.
Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study. Int
J Obes 1984;8:289-93.
Arvill A, Bodin L. Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men. Am J Clin Nutr 1995;61:585-9.
Zalewski BM, Chmielewska A, Szajewska H. The effect of glucomannan on body weight in overweight
or obese children and adults: A systematic review of randomized controlled trials. Nutrition 2015 31:437-442.
Zalewski BM, Chmielewska A, Szajewska H, Keithley JK, Li P, Goldsby TU, Allison DB. Correction of data errors and reanalysis of çThe effect of glucomannan on body weight in overweight or obese children and adults: A systematic review of randomized controlled trialsé. Nutrition 2015;31:1056-7.
Onakpoya I, Posadzki P, Ernst E. The efficacy of glucomannan supplementation in overweight and
obesity: a systematic review and meta-analysis of randomized clinical trials. J Am Coll Nutr 2014;33:70-8.
Pittler MH, Ernst E. Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med 2001;110:724-30.
an Heerden FR, Marthinus Horak R, Maharaj VJ, Vleggaar R, Senabe JV, Gunning PJ. An appetite suppressant from Hoodia species. Phytochemistry 2007;68:2545-53.
Blom WA, Abrahamse SL, Bradford R, Duchateau GS, Theis W, Orsi A, et al. Effects of 15-d repeated consumption of Hoodia gordonii purified extract on safety, ad libitum energy intake, and body weight in
healthy, overweight women: a randomized controlled trial. Am J Clin Nutr 2011;94:1171-81.
Downloads
เผยแพร่แล้ว
How to Cite
ฉบับ
บท
License
เนื้อหาและข้อมูลในบทความที่ตีพิมพ์ลงใน Thai JPEN วารสารโภชนบำบัด ถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรงซึ่งกองบรรณาธิการวารสารไม่จำเป็นต้องเห็นด้วยหรือร่วมรับผิดชอบใด ๆ
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ใน Thai JPEN วารสารโภชนบำบัด ถือเป็นลิขสิทธิ์ของ Thai JPEN วารสารโภชนบำบัด หากบุคคลหรืหน่วยงานใดต้องการนำทั้งหมดหรือส่วนใดส่วนหนึ่งไปเผยแพร่หรือเพื่อกระทำการใด จะต้องได้รับอนุญาตเป็นลายลักษณ์อักษรจาก Thai JPEN วารสารโภชนบำบัด ก่อนเท่านั้น
